Ovaries were graded into six categories: early follicular, mid follicular, late follicular, early luteal, mid luteal, and late luteal phases of the menstrual cycle. On histological examination, individual follicles were categorized as primordial, preantral, antral or preovulatory, and atretic follicles. Of the 36 patients included in this study, 9 had corpora lutea at the early (cycle days 14-18, n=3), mid (cycle days 19-24, n=3) and late (cycle days 25-28, n=3) stage of the luteal phase.
Immunohistochernical staining
Ovarian tissues obtained were fixed in 4% buffered neutral formalin, dehydrated and embedded in paraffin. Sections 5 to 6 ,um thick were deparaffinized and followed by standard histologic techniques.
Immunohistochemical staining was performed by avidin/biotin immunoperoxidase techniques with the use of a polyvalent immunoperoxidase kit (Omnitags, Lipshaw, Michigan) as previously described by Maruo and Mochizuki [20] . A mouse monoclonal antibody to human TGFa (Oncogene Science, Manhasset, NY), which specifically binds to human TGFa without crossreactivity with human EGF, was used as the primary antibody in this study. The anti-TGFa antibody (100 jig IgG/ml) was diluted 1:100 before use. The first incubation with primary antibody was followed by the second incubation with biotinylated polyvalent antibody, and by the third incubation with avidin-horseradish peroxidase. Chromogenic reaction was then developed by incubating with a freshly prepared solution of tetrahydrochloridediaminobenzidine and hydrogen peroxide. The sections were then counterstained with Harris hematoxylin, mounted with glycerine phosphate buffer solution, and examined microscopically.
The following control procedures were undertaken to assure the specificity of the immunologic reactions. Adjacent control sections were subjected to the same immunoperoxidase method with the exception that the primary antibody to TGFa was replaced by nonimmune murine IgG (Miles, Erkhart, Indiana) at the same dilution as the specific primary antibody. In the abovementioned controls, no positive staining was observed. Furthermore, preincubation with human recombinant TGFa (Bachem Fine Chemicals Inc., USA; 1 pg/ ml) before incubating with the monoclonal antibody to TGFa resulted in the abolishment of positive immunostaining of the ovarian compartments for TGFa, but preincubation with human recombinant EGF (Amersham, Arlington Heights, IL; 1 jig/m/) before incubating with the monoclonal antibody to TGFa did not alter the immunostaining of ovarian tissues for TGFa. The intensity of immunostaining was evaluated by repeated staining of the same specimens and by more than two observers.
It was graded as ( -) for no immunostaining, (+) for weak but definitely detectable immunostaining, ( + + ) for moderate immunostaining, and ( + + + ) for intense immunostaining.
Results
For the follicular phase of the menstrual cycle, the cytologic localization and cellular levels of TGFa in the follicular and stromal compartments of the human ovaries at the different stages of follicular growth are given in Table 1 . In primordial follicles, only the oocyte showed intense immun-°s taining for TGFa, whereas the stromal cells surrounding the primordial follicles were weakly immunostained for TGFa (Fig.1) . The earliest stage of follicular growth at which TGFa expression in granulosa and theca cells became apparent was the preantral follicular stage. In early preantral follil cles during the early follicular phase, not only the oocyte but also the granulosa cells were immunostained for TGFu ( Fig.2A) .
Replacement of the primary antibody with nonimmune murine IgG showed a lack of positive immunostaining of the oocyte, granulosa, theca cells and stromal cells (Fig.  2B) immunostaining of the ovarian elements for TGFa (data not shown).
As the size of the follicle increased, the staining intensity of the oocyte decreased, whereas the staining intensity of the granulosa and theca cells was augmented (Fig. 3) . The TGFa immunostaining in the granulosa cells and theca cells was pronounced in antral follicles during the mid follicular phase (Fig. 4) , and further intensified in preovulatory follicles during the late follicular phase (Fig. 5) . Table 2 summarizes the immunohistochemical localization and cellular levels of TGFa in luteal tissues and the surrounding stromal cells over the course of the luteal phase of the menstrual cycle. In corpora lutea during the early luteal phase, the lutein cells were immunostained for TGFa with a similar intensity as observed in the granulosa cells and theca cells in preovulatory follicles. The staining intensity of the lutein cells remarkably increased during the mid luteal phase of the menstrual cycle (Fig. 6A) , while the stromal cells surrounding the corpora lutea during the mid luteal phase showed weak immunostaining for TGFa. Replacement of the primary antibody with nonimmune murine
IgG showed a lack of positive immunostaining of the luteal cells and stromal cells (Fig. 6B) . In regressing corpora lutea during the late luteal phase, the staining intensity declined remarkably and the positive immunostaining for 
